Purpose: The aim of this study was to conduct preliminary studies in vitro and in vivo to assess the potential prebiotic effect of concentrate tart cherries juice.
Methods: Tart cherry juice concentrates, as well as representative polyphenol extracts, was used to set up in vitro assays (fecal slurries, simulator of the human intestinal tract microbial ecology) from which fecal samples were obtained and subjected to 16S rRNA gene sequence high throughput sequencing (MiSeq) and metabolomics through HPLC-qTOF-MS. A short-term dietary intervention study was conducted with 10 participants consuming the recommended amount of tart cherry juice daily over five days. Fecal samples were taken before and after the dietary intervention and subjected 16S rRNA gene sequence high throughput sequencing
Results: In the in vitro study, both tart cherry juices and chlorogenic acid (the main polyphenolic constituent of the juices) resulted in a significant increase of Lactobacillus and Bifidobacterium, correlating with an increase in Ruminococcus. The metabolomics indicated that, in contrast with sweet cherry juice, tart cherries polyphenols where predominantly converted to coumaric acid. A very recent indepedent study supported those microbiota and metabolomics trends at least for chlorogenic acid. Importantly, similar trends in gut microbiota were observed in most human subjects. It appeared that low initial abundance of Ruminococcus is limiting the "prebiotic" impact of tart cherries, potentially making it a keystone species.
Significance: To conclude, our results indicate a potential "prebiotic" effect of tart cherries polyphenols on the human healthy gut microbiota. Additional studies are under way to determine the metabolomics trends in the human samples, as well as metagenomic studies. Future studies are envisioned that would include strategies to stimulate Ruminococcus, thereby maximizing the prebiotic effect.